Previous Article | Next Article ![]()
Molecular and Cellular Biology, November 2001, p. 7523-7534, Vol. 21, No. 21
Department of Physiological Chemistry,
University Medical Center Utrecht, 3508 AB Utrecht, The Netherlands
Received 11 June 2001/Returned for modification 9 July
2001/Accepted 6 August 2001
The human RNA polymerase II transcription factor B-TFIID consists
of TATA-binding protein (TBP) and the TBP-associated factor (TAF)
TAFII170 and can rapidly redistribute over promoter DNA. Here we report the identification of human TBP-binding regions in human
TAFII170. We have defined the TBP interaction domain of
TAFII170 within three amino-terminal regions: residues 2 to 137, 290 to 381, and 380 to 460. Each region contains a pair of Huntington-elongation-A subunit-Tor repeats and exhibits
species-specific interactions with TBP family members. Remarkably, the
altered-specificity TBP mutant (TBPAS) containing a triple
mutation in the concave surface is defective for binding the
TAFII170 amino-terminal region of residues 1 to 504. Furthermore, within this region the TAFII170 residues 290 to 381 can inhibit the interaction between Drosophila TAFII230 (residues 2 to 81) and TBP through competition for
the concave surface of TBP. Biochemical analyses of TBP binding to the
TATA box indicated that TAFII170 region 290-381 inhibits
TBP-DNA complex formation. Importantly, the TBPAS mutant is
less sensitive to TAFII170 inhibition. Collectively, our
results support a mechanism in which TAFII170 induces
high-mobility DNA binding by TBP through reversible interactions with
its concave DNA binding surface.
Initiation of mRNA synthesis by RNA
polymerase (pol) II requires the basal transcription factors TFIID,
TFIIB, TFIIE, TFIIF, and TFIIH. Recognition of the TATA box within core
pol II promoters by TFIID initiates the assembly of a functional pol II
preinitiation complex. TFIID is a multisubunit complex consisting of
TATA-binding protein (TBP) and at least 10 TBP-associated factors
(TAFIIs) ranging in size from 15 to 250 kDa.
TAFIIs play several roles in transcriptional
regulation, serving as coactivators, promoter selectivity factors, or
enzymes that modify surrounding transcriptional proteins
(3). The TBP subunit recognizes the TATA box forming the
TBP-TATA complex (24). Structural studies of the TBP-TATA complex indicate that the Of relevance to this study is that the largest
TAFII subunit of TFIID
(dTAFII230 in Drosophila,
hTAFII250 in humans, and
yTAFII145/130 in yeast), can inhibit TBP binding
to the TATA box (11, 31, 33).
dTAFII230 achieves this by interacting with the
concave DNA binding surface of TBP (see references cited above).
Residues 2 to 81 (called TAND I) undergo a disorder-to-order transition upon interaction with TBP. The induced structure of TAND I mimics the
structure of the TATA box when bound to TBP (34). A second N-terminal inhibitory domain (TAND II; residues 82 to 156) blocks the
TBP-TFIIA interaction by competitively binding to helix 2 (H2) on the
convex surface of TBP (10). The orthologous
TAFII subunits from yeast and humans contain
regions which are functionally equivalent to TAND I and TAND II despite
a low degree of primary sequence similarity (33).
TAFII-containing complexes distinct from TFIID
have been described. Examples include the yeast SAGA and human PCAF and
TFTC complexes (3). In addition to these, it has been
reported previously that the majority of TBP in mammalian cell extracts
is present in the B-TFIID complex (49). In this distinct
complex TBP is associated with a single TAFII,
TAFII170 (49, 50). B-TFIID can
support TATA-dependent transcription in reconstituted basal transcription experiments as efficiently as TBP or TFIID
(49). Notably the complex displays several biochemical
properties that make it distinct from traditional TFIID. Firstly, pol
II transcription with B-TFIID is not responsive to activators
(49). Secondly, B-TFIID exhibits dATPase activity that can
be attributed to the TAFII170 subunit
(50). Finally, B-TFIID binds unstably to the TATA box,
which may explain its inability to commit a template for transcription
(49).
hTAFII170 has also been cloned as TAF172
(16; referred to in this paper as
TAFII170). hTAFII170 is the
human ortholog of yMot1 (16, 50), and both are members of
the SNF2 family of DNA-dependent ATPases (42).
MOT1 was originally identified by genetic screens for
enhanced basal transcription in yeast (20). Independent
studies showed Mot1 protein to exist in a complex with TBP distinct
from yTFIID (43). Mot1 protein was identified as an
ATP-dependent inhibitor activity in yeast nuclear extracts that removed
TBP from the TATA box using the energy of ATP hydrolysis (6). Interestingly, amounts of Mot1 stoichiometric to TBP
weakly stimulate TBP-dependent transcription, whereas a molar excess of
Mot1 leads to a repression of transcription (17, 36,
39). Studies with Mot1 have shown that the release of TBP
from DNA does not appear to involve an ATP-dependent DNA tracking over distances as short as 40 bp (2, 7). Furthermore,
Mot1-catalyzed disruption of TBP-DNA complexes does not appear to
involve DNA strand separation, DNA bending, or twisting of the helix
(2, 7). Rather, it has been proposed that Mot1 displaces
TBP from DNA by translocation through the TATA box in an ATP-dependent manner (2, 7). Deletion analysis shows that this function requires a 17-bp double-stranded DNA "handle" upstream of the TATA
box, indicating that Mot1 contacts upstream DNA (19).
Several observations indicate that Mot1 interacts with H2 on the convex surface of yTBP (1, 5, 6, 15), which led to the hypothesis that Mot1 can also distort TBP conformation in a "power stroke" action leading to TBP-TATA dissociation (2, 8). However, to date there have been no experimental data to support this. Besides
Mot1 being a repressor of transcription, there is also a link
between Mot1 and activation of transcription. Mot1 may activate
transcription by redistributing a limiting pool of TBP between DNA
sites in vitro and in vivo (17, 36, 39). Notably, TAFII170, like Mot1, uses the energy of ATP
hydrolysis to dissociate TBP from DNA (16).
An important issue is the observation that in contrast to TBP or TFIID,
B-TFIID does not form highly stable complexes with the TATA box in the
absence of ATP (49). We therefore set out to establish how
the hTAFII170/hTBP interaction relates
mechanistically to the TATA box-binding properties of B-TFIID. We first
sought to establish the hTBP interaction domain of
hTAFII170 and show that three regions within the
amino-terminal third of hTAFII170 are involved in
the interaction. We found that these regions are critical for the
binding of hTAFII170 to hTBP and exhibit
species-specific interactions with TBP family members. Strikingly, the
concave DNA binding surface of hTBP is crucial for this interaction.
This led to the finding that a small domain of
hTAFII170 within its amino-terminal part could
inhibit TBP-TATA complex formation. Our results support a model in
which insertion of this hTAFII170 domain into the
DNA binding cavity of hTBP inhibits its interaction with the TATA box
and explains the DNA binding properties of B-TFIID. Reversibility of
this process would allow for rapid redistribution and increased
mobility of hTBP on DNA.
Plasmids.
pJGhTBP was created by cloning a SalI
(blunt)-XhoI fragment from pRSVhIID into the
EcoRI (blunt) and XhoI sites of pJG4-5. pJGTBPAS was generated by cloning a
DraIII-ClaI fragment from pSRaMSVtkneohTBPm3e
(14) into the DraIII and ClaI sites
of pJGTBP. To create the pEG202-hTAFII170
derivatives NdeI-AocI (1-504), BamHI-AocI (136-504), BspHI
(1133-1849), and XmaI (blunt)-BspHI (505-1133),
fragments from hTAFII170 cDNA were cloned into
pEG202. The remaining pEG-hTAFII170 plasmids were
created from pEG-hTAFII170 (1-504) by using a
double-stranded, nested-deletion kit (Pharmacia Biotech). pAC-TAF
(2-460) was created by cloning a PCR fragment generated from
hTAFII170 cDNA into the XhoI and
NotI (blunt) sites of pACYC. All other
pAC-hTAFII170 constructs were created by cloning PCR fragments amplified from pAC-TAF (2-460) into the SpeI
and XhoI sites of pAC-TAF (2-460). To generate glutathione
S-transferase (GST)-Flag-TAF fusions,
NdeI-SpeI fragments from
pAC-hTAFII170 derivatives were cloned into the
NdeI and SpeI sites of modified pGEX-2T. To
prepare His-tagged dTAFII230 (2-81),
dTAFII230 (82-156), and
dTAFII230 (2-156), corresponding DNA from
pGEX-dTAFII230 (2-156) (a kind gift from Y. Nakatani) was PCR amplified as SalI-BamHI fragments and subcloned into pET15b (Novagen). pGST-TFIIS was created
by cloning an NdeI-BamHI fragment from
pET22-TFIIS (a kind gift from C. Kane) into the NdeI and
BamHI sites of pGEX-2T. For expression of full-length
hTAFII170 in mammalian cells,
pMT2-hTAFII170 was created by cloning a
NaeI-StuI fragment from
pET-hTAFII170 into the SmaI site of
pMT2-SM. pSG-ehTBP and pSG-ehTBPm3e (kind gifts from H. Stunnenberg)
and pSG-ehTBPK243E were used for expression of full-length hTBP in
mammalian cells (see Fig. 5B). pSG-ehTBPK243E was created by
oligonucleotide-mediated, site-directed mutagenesis using pSG-ehTBP as
the template.
Yeast two-hybrid analysis.
Yeast strain EGY48 was
transformed with the hTAFII170 derivatives
harbored in the bait vector pEG202, either pJG-hTBP or
pJG-hTBPAS accompanied by pSH18-34 (Invitrogen)
harboring the lacZ reporter in accordance with the standard
lithium acetate method (9). Transformants were selected on
His/Trp/Ura-deficient plates and patched onto His/Trp/Ura/Leu-deficient
plates containing
5-bromo-4-chloro-3-indolyl- Protein expression.
Escherichia coli strain
BL21(DE3) containing pGEX-hTBP, pGEX-TFIIS,
pGEX-Flag-hTAFII170 derivatives,
pET15b-dTAFII230 derivatives, or
pAC-hTAFII170 derivatives was cultured at 37°C
in 50 ml of Luria-Bertani medium containing ampicillin (100 µg/ml)
or, in the case of pAC-hTAFII170 derivatives,
chloramphenicol (25 µg/ml). At an optical density at 600 nm of 0.5 to
0.6, the cells were induced with
isopropyl- Purification of GST-Flag-hTAFII170,
His-dTAFII230 derivatives, and hTBP proteins.
GST-Flag-TAFII170-containing lysates were
prepared on a 2-liter scale as described above and loaded onto a
glutathione agarose column. The column was washed with lysis buffer (20 mM HEPES-KOH, pH 8.05, 20% glycerol, 300 mM KCl, 0.01% Triton X-100,
1 mM EDTA, and protease inhibitors) and eluted with lysis buffer
containing 15 mM glutathione. Peak fractions were pooled and dialyzed
against A100 buffer (20 mM HEPES-KOH, pH 7.9, 20% glycerol, 100 mM KCl, 0.5 mM EDTA, 1 mM dithiothreitol, and 0.5 mM
PMSF). The amount of eluted protein was determined by Bio-Rad protein
assays (Bio-Rad) using bovine gamma globulin as a standard and
Coomassie blue staining of sodium dodecyl sulfate (SDS)-polyacrylamide
gel electrophoresis gels. Proteins were negative for RNase activity as
analyzed by incubation with radiolabeled RNA.
His-dTAFII230 derivatives were batch purified by
mixing clarified lysates containing 20 mM imidazole with
Ni-nitrilotriacetic acid agarose (Qiagen) for 2 h at 4°C with
gentle shaking. The slurry was washed two times in wash buffer (50 mM
Tris-HCl, pH 8.0, 20% sucrose, 1 mM EDTA, 0.3 M KCl, 0.01% Triton
X-100, 20 mM imidazole, 0.5 mM PMSF, 0.2 mM sodium metabisulfite, 1 µg of aprotinin/ml, and 1 µg of leupeptin/ml), and the
His-dTAFII230 proteins were eluted in wash buffer
containing 300 mM imidazole for 30 min at 4°C with gentle shaking.
His-hTBP was expressed in E. coli and purified as
described previously (26). For Fig. 6C, recombinant hTBP
and altered- or relaxed-specificity hTBP (hTBPAS)
were expressed as GST fusions in E. coli and
purified as described for the GST-Flag-TAFII170
derivatives, with the following modifications: after glutathione
agarose chromatography, peak hTBP fractions, as judged by Coomassie
staining of protein gels, were pooled and the GST tag was removed by
cleaving the pooled hTBP preparations with thrombin (1 IU/0.8 mg of
protein) for 4 h at 37°C. Thrombin was removed by batch
purifying the hTBP preparations with benzamidine Sepharose 6B (Sigma).
The preparations were dialyzed against A100 buffer and
subsequently batch purified with glutathione agarose to remove GST and
uncleaved hTBP fusion protein. The preparations were then applied to a
5-ml HiTrap heparin cartridge (Pharmacia Biotech). The column was
developed by a linear gradient from 0.1 to 1.0 M KCl in buffer A over
10 column volumes. hTBP fractions with the highest specific activity,
as judged by gel shift analysis, were used for subsequent experiments.
GST fusion protein interactions.
To analyze interactions
between hTAFII170 and hTBP or TBP family members,
bacterial lysates containing equivalent levels of Flag-hTAFII170 derivatives were incubated with
bacterial lysate containing equivalent levels of GST-TBPs or GST-TFIIS
and 100 µl of prewashed glutathione beads in 500 µl of binding
buffer (50 mM Tris-HCl, pH 8.0, 1 mM EDTA, 20% glycerol, 300 mM KCl
[unless otherwise indicated], 0.01% Triton X-100, and protease
inhibitors). Reactions were performed at 4°C for 3 h with
rotation. Complexes were washed in binding buffer eluted in SDS sample
buffer, and Flag-tagged hTAFII170 proteins were
analyzed by Western blotting with Coimmunoprecipitation analysis.
COS-7 cells at approximately
70% confluency were washed in phosphate-buffered saline; resuspended
with 5 µg of pSG-ehTBP, pSG-ehTBPm3e, or pSG-ehTBPK243E and 15 µg
of pMT2-hTAFII170; and electroporated with a
1.2-kV pulse at 25 µF (gene pulser; Bio-Rad). After transfection (48 h) cells were lysed in ELB buffer (50 mM HEPES-KOH, pH 7.9, 150 mM KCl, 5 mM MgCl2, 0.5 mM EDTA, 0.1%
NP-40, 1 mM Protein-DNA interaction assays.
Gel mobility shifts were
performed with 5,000 cpm (approximately 0.1 ng) of
32P-labeled adenovirus major late promoter
(AdMLP) probe ( In vitro transcription.
Transcription reactions using 25 ng
of linearized template pAdML(C2AT) The amino terminus of hTAFII170 interacts with
hTBP.
Determining interaction surfaces within the B-TFIID complex
is hampered because B-TFIID cannot be efficiently reconstituted from
its isolated components (16, 50). Therefore, we exploited the yeast two-hybrid system to reconstitute hTBP and
hTAFII170 interactions in vivo. Full-length
hTAFII170 is not expressed efficiently as a LexA
fusion in yeast. Therefore, three LexA DNA binding domain fusion
constructs spanning hTAFII170 (residues 1 to 504, 505 to 1133, and 1133 to 1849) were constructed and tested for
interaction with hTBP fused to the B42 activation domain (Fig.
1A). The 1-504 construct shows a strong
interaction with hTBP in contrast to the 505-1133 and 1133-1849 constructs (Fig. 1A). Region 1-455 is sufficient for hTBP interaction,
but continued deletions result in hTAFII170
fusions that activate transcription in the absence of exogenous
B42-hTBP (Fig. 1A and data not shown). Nevertheless, with the 1-359 construct, an interaction with hTBP was still seen above this
background (Fig. 1A). Deletion of the first 135 residues results in a
twofold decrease in hTBP interaction (Fig. 1A). Western blot analysis
confirmed that all LexA-hTAFII170 deletion
mutants that failed to interact with hTBP were expressed (Fig. 1B,
lanes 1 to 4) and resided in the nucleus as indicated by the JK101
repression test (data not shown). Thus, the yeast two-hybrid analysis
of the hTAFII170-hTBP interaction indicates that
amino-terminal residues 1 to 504 of hTAFII170 are
important for the interaction with hTBP. This agrees with deletion
studies of Mot1 which showed that the first 1,200 amino-terminal
residues are involved in contacting DNA-bound yTBP (8)
while the first 800 amino-terminal residues can contact free yTBP
(1).
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.21.7523-7534.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
TAFII170 Interacts with the Concave
Surface of TATA-Binding Protein To Inhibit Its DNA Binding
Activity


![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
sheets of TBP form a concave undersurface which contacts the minor groove of the TATA box (28, 29).
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
-D-galactopyranoside (X-Gal) and galactose. Interactions were scored by measurement of
growth of blue colonies and quantitative determination of
-galactosidase activity as described previously (38).
-D-thiogalactopyranoside (IPTG) (0.4 mM). After 3 h cells were harvested and the cell pellet was
resuspended in 4 ml of lysis buffer (50 mM Tris-HCl, pH 8.0, 20%
sucrose, 1 mM EDTA, 0.3 M KCl, 0.01% Triton X-100, 1 mM
dithiothreitol, 0.5 mM phenylmethylsulfonyl fluoride [PMSF], 0.2 mM
sodium metabisulfite, 1 µg of aprotinin/ml, and 1 µg of
leupeptin/ml). The cells were incubated on ice with 200 µg of
lysozyme/ml and lysed by freeze-thawing and sonication, and the
bacterial lysate was cleared by ultracentrifugation.
Flag M2 (Kodak). For analysis of
hTAFII170 and His-hTBP interactions, bacterial
lysates containing equivalent levels of GST-Flag-hTAFII170 derivatives or GST-TFIIS were
incubated with His-hTBP (460 ng) as described above. His-hTBP was
analyzed by Western blotting with 20C7 (
-TBP). To examine
interactions between GST-Flag-hTAFII170,
His-hTBP, and His-dTAFII230 derivatives,
bacterial lysates containing equivalent levels of
GST-Flag-hTAFII170 derivatives were incubated
with His-hTBP (72 ng) and 180, 60, 20, and 6.6 pmol of batch-purified
His-dTAFII230 TAND I or II lysate or 60, 20, 6.6, and 2.2 pmol of batch-purified His-dTAFII230 TAND
I and II lysate as described above. His-hTBP was analyzed by Western blotting with 20C7 (
-TBP).
-mercaptoethanol, and protease inhibitors). For
coimmunoprecipitation, COS-7 cell lysates were incubated in ELB buffer
with 10 µg of
-TBP (1F8) or 10 µg of
-c-Myc (9E10) with
rotation at 4°C. After 4 h, prewashed protein G beads were added
to recover immunoprecipitates and were washed in ELB buffer and
hTAFII170 proteins were analyzed by Western
blotting with 5115 (
-TAFII170)
(50).
53 to +33), 0.2 pmol of His-hTBP or GST-cleaved TBPs,
160 ng of partially purified hTFIIA, and purified
GST-Flag-hTAFII170 derivatives for 30 min at
30°C in a buffer containing 18.5 mM HEPES-KOH, pH 7.9, 18.5%
glycerol, 5 mM MgCl2, 0.5 mM EDTA, 50 µg of
poly(dG-dC)/ml, 0.2 mg of bovine serum albumin/ml, and 60 to 80 mM KCl. Reactions were resolved on a 4% Tris-glycine gel. DNase I
footprinting was performed with 12,500 cpm (approximately 0.5 ng) of
32P-labeled AdMLP probe (
17 to +33), purified
GST-Flag-hTAFII170 derivatives, and 6.0 pmol of
His-hTBP under standard gel shift conditions. DNase I (1.5 U) was added
and the reactions were incubated for 1 min. DNase I was inactivated by
addition of an equal volume of stop mix (2% SDS, 200 mM EDTA). DNA was
recovered by ethyl alcohol precipitation and analyzed on a 6%
urea-Tris-borate-EDTA gel.
400 were
performed as previously described (49). Reactions
contained bacterially derived His-hTBP (0.24 pmol), TFIIB (60 ng),
TFIIE (150 ng), purified GST-Flag-hTAFII170
derivatives and baculovirus-expressed TFIIF (40 ng), purified HeLa
cell-derived TFIIH (0.5 µl), and calf thymus RNA pol II (0.4 µl).
Purification of transcription factors was performed as previously
described (26). RNA was recovered as previously described
(49). Recovery control RNA was synthesized as
described above from linearized pAdML(C2AT)
200.
![]()
RESULTS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

View larger version (25K):
[in a new window]
FIG. 1.
Interaction of hTAFII170 with hTBP and
hTBPAS in the yeast two-hybrid system. (A) Schematic
representation of the various LexA-hTAFII170 deletion
mutants and relative
-galactosidase activities. Yeast strain EGY48
was transformed with the indicated LexA-hTAFII170
expression plasmids and B42-hTBP or B42-hTBPAS expression
plasmids together with a lacZ reporter gene containing
LexA operators.
-Galactosidase activities were expressed as fold
activation relative to the
-galactosidase activity of yeast cells
expressing the LexA fusion and the unfused B42 activation domain only.
Quantifications were performed in triplicate. ND, not determined. (B)
Expression of LexA-hTAFII170 derivatives in yeast. Yeast
samples containing equal amounts of cells were prepared from cultures
harboring the LexA-hTAFII170 expression plasmids (lanes 1 to 4) and were analyzed using LexA antibodies.
Three regions in the amino terminus of TAFII170 can
independently bind hTBP.
To avoid self-activation problems in the
yeast two-hybrid system, we developed a direct protein-protein binding
assay to further delineate the hTBP interaction domain of
hTAFII170. A series of amino- and
carboxy-terminal deletion mutants of Flag-tagged
hTAFII170 residues 2 to 460 were analyzed for
their ability to interact with GST-hTBP (Fig.
2A to E). As specificity
controls, binding to a GST fusion of the active part
of the elongation factor hTFIIS (Fig. 2A to E) or to GST alone (data
not shown) was analyzed. Consistent with the yeast two-hybrid data,
region 137-460 is specifically retained by GST-hTBP (Fig. 2A to C, lane
6; D, lane 7; and E, lane 6). Analysis with amino-terminal truncations
revealed that residues up to 336 could be removed without affecting the
interaction with hTBP (Fig. 2A, lanes 6 to 10). Similarly,
carboxy-terminal truncations demonstrated that removal of residues to
361 had no effect (Fig. 2B, lanes 6 to 8). However, deletions extending
to residues 311 abolished the interaction with hTBP (Fig. 2B, lanes 9 and 10). Thus, these analyses define a region of 23 residues between
337 and 360 important for the interaction with hTBP. Consistently, a
more extensive carboxy-terminal deletion removing residues to 347 abolished hTBP-binding activity (Fig. 2C, lane 10).
|
-helices (22, 40).
Strikingly, the predicted HEAT repeats of
hTAFII170 overlap with its TBP-binding regions, with each containing a pair of HEAT repeats (Fig. 3A and B). Outside these regions, hTAFII170 orthologs display a
lower degree of similarity (16, 50). Collectively, this
suggests that the TBP-binding regions of
hTAFII170 have been conserved during evolution
and that the HEAT repeat motifs mediate TBP interaction.
|
The hTAFII170 amino-terminal regions show
species-specific interactions with TBP family members.
The core
region of hTBP is highly conserved throughout evolution
(25). In addition, recent studies have revealed the
existence of the close TBP homologs TBP-like factor (TLF) and
TBP-related factor (TRF) and have demonstrated their importance for the
regulation of transcription (18). This prompted us to
examine if the hTAFII170 amino terminus could
interact with various TBP family members. GST fusions of dTBP, yTBP,
and C. elegans TLF (ceTLF) and dTRF-1 were tested
for their ability to retain the hTAFII170 amino
terminus. The hTAFII170 amino terminus (residues
2 to 460) was specifically retained by yTBP and dTBP with comparable
efficiency to that of hTBP (Fig. 4A;
lanes 2 to 4). In contrast, poor binding to ceTLF was observed (Fig.
4A, lane 5). The hTAFII170 amino terminus also interacted with dTRF-1 but with a slightly lower efficiency than did
hTBP (Fig. 4A, lane 6).
|
The amino terminus of hTAFII170 interacts with concave DNA binding surface of hTBP. Biochemical and genetic evidence suggests that Mot1 interacts with specific residues on H2 at the convex surface of yTBP overlapping the TFIIA-binding site (1, 5, 6, 15). To investigate the hTBP determinants for binding hTAFII170, we planned to test in the yeast two-hybrid assay hTBP convex surface mutants previously examined for loss of specific biochemical activities (14). These mutants were generated in the background of TBPAS. This TBP molecule contains a triple mutation in its concave surface (I292F, V301T, L303V) resulting in a relaxed specificity for TATA binding (45). As a control in the two-hybrid system we tested the interaction between hTBPAS and the amino terminus of hTAFII170 (Fig. 1A). To our surprise, hTBPAS failed to interact with hTAFII170 regions 1-504 and 136-504 (Fig. 1A). Western blot analysis indicated that wild-type hTBP and hTBPAS were expressed to similar levels (data not shown). This suggests that residues in the concave DNA binding surface of hTBP are important for interaction with the TAFII170 amino terminus, so we decided to test this possibility further.
TAND I (residues 2 to 81) of dTAFII230 blocks TBP-TATA box binding by direct occupancy of the concave DNA binding face of TBP, whereas TAND II competes with TFIIA for binding to H2 on the convex surface of TBP (31, 33, 34, 41). To elaborate the interaction between the amino terminus of hTAFII170 and the concave surface of hTBP, we tested whether TAND I of dTAFII230 and the hTAFII170 regions compete in an hTBP-binding assay. Histidine-tagged TAND I and TAND I and II together, but not TAND II alone, inhibited the interaction between hTBP and GST-Flag-hTAFII170 region 290-381 in a dose-dependent manner (Fig. 5A, lanes 2 to 13). In conclusion, results of the yeast two-hybrid and GST pulldown assays indicate that the amino terminus of hTAFII170 contains a region which can bind to the concave DNA binding surface of hTBP and influences its DNA binding properties.
|
The amino-terminal regions of hTAFII 170 inhibit
hTBP-TATA box interaction.
To address whether the interaction
between the amino-terminal part of hTAFII170 and
the concave surface of hTBP influences the hTBP-TATA interaction, gel
mobility shift analyses with hTBP, TFIIA, and a DNA fragment of the
AdMLP TATA box were performed in the presence of the
hTAFII170 amino-terminal regions. A complex corresponding to hTBP-TFIIA-TATA, TA, could be observed
in the absence of
hTAFII170 (Fig. 6A and B, lanes
1, 6, 11, 17, 22, and 27). Addition of purified
GST-Flag-hTAFII170 region 2-460 or 290-381 simultaneously with the probe, hTBP, and TFIIA inhibited the TA complex
in a dose-dependent manner (Fig. 6A, lanes 2 to 5 and 18 to 21).
Consistent with its strong hTBP-binding activity, region 290-381 efficiently inhibited the TA complex (Fig. 6A, lanes 18 to 21).
However, the TA complex was less efficiently inhibited by region
380-460 (Fig. 6B, lanes 18 to 21) and was unaffected by region 2-137 (Fig. 6B, lanes 2 to 5), both of which bind hTBP weakly. The inhibition
was specific since the GST-Flag-hTAFII170 fusion
proteins had no effect on protein-DNA complexes formed by the E-box
protein, Max (data not shown). Inhibitory effects were also observed if
the hTAFII170 amino-terminal regions were preincubated with hTBP prior to the addition of TFIIA and probe (Fig.
6A and B, lanes 7 to 10 and 23 to 26). Notably, preassembly of the TA
complex rendered it largely refractory to the inhibitory effect of
hTAFII170 regions 2-460, 290-381, and 380-460 (Fig. 6A and B, lanes 12 to 15 and 28 to 31). This is expected because TBP-TATA complexes are relatively stable and, thus, the concave DNA
binding surface is not available after TA complex formation. Similarly,
hTBP-TFIIA-TFIIB-TATA complex formation was also inhibited by the
hTAFII170 regions 2-460 and 290-381 (data not
shown). Together these results indicate that the amino-terminal regions
2-460, 290-381, and, to a lesser extent, 380-460 are capable of
inhibiting the TBP-TATA interaction.
|
|
The amino-terminal regions of hTAFII170 inhibit RNA pol
II transcription in vitro.
The full-length yMot1 (D1408N)
mutant and yMot1 amino-terminal fragments whose ATPase activity has
been abolished act as dominant negatives by forming stable dead-end
complexes with yTBP (1, 8). The ability of the isolated
290-381 region of hTAFII170 to inhibit hTBP-TATA
interaction by blocking the concave surface of hTBP suggests that these
regions could also act in a dominant-negative fashion to inhibit in
vitro transcription by binding and sequestering hTBP. To test this
idea, hTBP binding regions 2-460 and 290-381 were added to a
reconstituted pol II transcription system dependent upon hTBP. In vitro
transcription reactions were reconstituted with bacterially derived
hTBP, TFIIB, and TFIIE; baculovirus-expressed TFIIF; purified HeLa
cell-derived TFIIH; and immunoaffinity-purified calf thymus pol II (see
Materials and Methods). Transcription was analyzed from a linearized
AdMLP core promoter (
53 to +10) that drives transcription of a 380-bp
guanosine (G)-less cassette. Addition of equivalent amounts of
purified GST-Flag-hTAFII170 region 2-460 or
290-381 to the reactions decreased transcription from the AdMLP (Fig.
8, lanes 2 to 4 and 8 to 10).
Quantitation of transcript levels corrected by using a labeled internal
standard RNA indicated that the regions 2-460 and 290-381 repressed pol II transcription by approximately 1.6 and 3.0-fold, respectively, at
the highest amount used (Fig. 8, lanes 2 and 8). The stronger inhibition seen with the 290-381 region correlates well with its ability to bind hTBP more strongly, inhibit the
dTAFII230/hTBP interaction, and inhibit hTBP-TATA
complex formation, compared to region 2-460. Notably, the effect of
these regions in transcription is less pronounced than that observed in
the gel mobility shift and DNase I footprint analyses (Fig. 6 and 7).
Possibly basal transcription factors present in the transcription
reactions can partially relieve the
hTAFII170-mediated inhibition (see Discussion). As expected, the weak TBP-binding region 2-137 had little or no effect
(Fig. 8, lanes 5 to 7). These results indicate that pol II
transcription can be directly repressed by region 290-381 of hTAFII170. This is consistent with the view that
this region is capable of inhibiting the hTBP-TATA interaction by
directly blocking the DNA binding surface of hTBP.
|
| |
DISCUSSION |
|---|
|
|
|---|
The basal transcription factor B-TFIID supports pol II transcription as efficiently as TBP or TFIID in reconstituted basal transcription assays (49). However, in contrast to TBP or TFIID, B-TFIID displays dynamic binding to the TATA box. In an effort to understand the apparent high on and off rates of B-TFIID for DNA binding, we analyzed the interaction regions of its hTBP and hTAFII170 constituents. Our analysis indicates that the concave surface of TBP responsible for DNA binding is an important determinant for hTAFII170 action.
Our biochemical analyses mapped hTBP-binding domains in hTAFII170 to three regions within its amino-terminal third: residues 2 to 137, 290 to 381, and 380 to 460. The stable interaction of these regions with hTBP at increasing salt concentrations (300 to 600 mM) suggests that the interaction of the amino terminus of hTAFII170 with hTBP is sustained mainly by hydrophobic interactions. These regions are also important in the context of full-length hTAFII170, as we were unable to coimmunoprecipitate hTBP and full-length hTAFII170 from cell extracts when these regions were removed (data not shown). Yeast two-hybrid analysis indicated that the hTAFII170 ATPase domain alone is unable to interact detectably with hTBP. In addition we were also unable to coimmunoprecipitate hTBP and the isolated hTAFII170 ATPase domain from cellular extracts (data not shown). Consistent with this, the Mot1 ATPase domain cannot bind yTBP in the absence or presence of DNA (1, 2, 8). Together our results fit with the suggestion that the ATPase domain of hTAFII170-related proteins like Mot1 is targeted to its TBP substrate via the amino terminus (6, 8).
The importance of the hTAFII170 amino-terminal regions in contacting hTBP is consistent with previous findings that the first 800 residues of Mot1 are responsible for binding yTBP (1, 8). Furthermore, in the hTAFII170 ortholog, Drosophila 89B helicase (21), the first 825 residues can bind to dTBP (1). The corresponding TBP-binding regions in hTAFII170, Mot1, and 89B helicase also share common, highly related blocks (Fig. 3A). These observations indicate that the role of the amino terminus of hTAFII170 orthologs in TBP binding has been conserved during evolution. Furthermore, recent computational analysis indicated that these regions of hTAFII170 and Mot1 share clusters of tandemly arrayed HEAT repeats (4, 40). hTAFII170 contains six HEAT repeats within the first 460 residues. A pair of predicted HEAT repeats of hTAFII170 overlap with each of its TBP-binding regions (Fig. 3A and B). Together this suggests that the HEAT repeat protein motifs mediate TBP interaction in hTAFII170 orthologs.
Our results show that the amino-terminal regions of hTAFII170 exhibit species-specific interactions with TBP family members. While hTAFII170 region 2-460 interacted with yTBP remarkably well, when individually assayed the TBP-interacting regions showed poor binding. This may relate to specific differences between yTBP and hTBP. The binding of hTAFII170 region 290-381 to dTRF-1 suggests a functional link between 89B helicase (21) and dTRF-1 (47). Consistent with this, residues 1 to 825 of 89B helicase can bind dTRF-1 (1). This latter protein plays a role in directing transcription by RNA pol III (47). In this context it is interesting that hTAFII170 has been linked to RNA pol III transcription in vitro (46). However, other biochemical and genetic analyses have failed to observe an involvement of B-TFIID and Mot1 in pol III transcription (6, 37).
The most striking finding of our analyses is that an amino-terminal region of hTAFII170 can target the DNA binding concave surface of hTBP. First, we have not only shown that hTBPAS does not bind efficiently to the amino terminus of hTAFII170 or to full-length hTAFII170 in vivo but also that the region 290-381 of hTAFII170 can compete with dTAFII230 (TAND I) for binding the concave face of hTBP. Second, our biochemical evidence clearly shows that both regions 2-460 and 290-381 can inhibit hTBP-TATA box interaction. Notably, the effect of the hTAFII170 regions 2-460 and 290-381 in TATA-dependent in vitro transcription was less pronounced, in spite of the strong effect that they had on TBP-TATA complex formation in gel mobility shift and DNase I footprinting analyses. It is possible that stabilization of the TBP-TATA interaction by basal transcription factors such as TFIIA, TFIIB, and TFIIE (27, 51) partially counteracts the repressing activity of this hTAFII170 region. Alternatively, the effects of TFIIA, TFIIB, or TFIIE may be attributable to a block of hTAFII170 interaction with hTBP. Thirdly, the hTBPAS-TATA box interaction is less sensitive to inhibition by the hTAFII170 amino terminus. Together these results provide a rationale for the previous observation that B-TFIID cannot bind stably to the TATA box (49). Region 290-381 of hTAFII170 can compete with the TATA box for interaction with the concave DNA binding surface of hTBP. This is supported by the recent observations of Darst and coworkers (19) that preincubation of Mot1 with yTBP off DNA inhibits subsequent DNA binding by yTBP.
Previous mutational analyses indicate that amino acid residues of the yTBP H2 convex surface are important for the interaction between yTBP and Mot1 (1, 15). Furthermore, TFIIA has been shown to bind to H2 of the convex surface of yTBP competitively with Mot1 (5, 6, 15). Our observation that a single mutation at K243 of hTBP severely disrupts binding of full-length hTAFII170 in vivo suggests that hTAFII170 also interacts with the convex surface of hTBP. Together, with our observation that hTAFII170 binds the concave surface of hTBP, these results suggest that hTAFII170 can interact with multiple surfaces of hTBP. The behavior of hTAFII170 regions 2-137 and 380-460 was distinct from that of 2-460 and 290-381. Both bound to hTBP but had relatively minor, if any effects, on dTAFII230/TBP or TBP-TATA interactions (Fig. 7 and 8; data not shown). This distinct behavior may reflect an unstable interaction with the hTBP concave surface. Alternatively, these regions may contact the convex surface of hTBP. In that case one would expect higher-order complexes with these regions in gel shift analyses. Although this was not observed, TFIIA present to stabilize hTBP-TATA binding in these analyses may have competed with hTAFII170 regions 2-137 and 380-460. Therefore, in this context we cannot conclude whether these regions bind the hTBP convex surface.
It has been proposed that displacement of TBP from DNA by Mot1 involves an ATP-driven power stroke which relieves a conformationally strained Mot1 to pull the TBP-DNA complex apart (8). This was suggested to involve conformational changes in TBP (2). Our findings imply a different mechanism for the regulation of the TBP-TATA interaction by hTAFII170/Mot1 and how this relates to the TATA box-binding properties of B-TFIID. In its simplest form we propose a model for B-TFIID function in which B-TFIID can convert from an active to a blocked conformation and vice versa. In the blocked conformation, access of TBP to promoter DNA would be precluded by the presence of region 290-381 of hTAFII170 in the DNA binding cavity of TBP. This would explain the inability of B-TFIID to stably interact with TATA box DNA (49). In the active conformation, region 290-381 is absent from the concave surface and TBP is free to interact with promoter DNA. The ability of B-TFIID to support TATA-dependent transcription (49) could reflect this conformation. In this respect it is important to determine whether hTAFII170/Mot1 is still associated with TBP when the latter is bound to active promoters. Alternatively, hTAFII170/Mot1 may dissociate when TBP is assembled into an active preinitiation complex. An essential feature of our proposed model would be conversion between the active and blocked states. It is likely that the ATPase function of hTAFII170/Mot1 is involved in this conversion. As mentioned, dissociation of preformed TBP-TATA complexes by hTAFII170/Mot1 requires ATP hydrolysis (5, 6, 16). Future work using mutagenesis and single-molecule studies is required to more directly test these possibilities.
hTAFII170 shows the same pattern of TBP-TATA complex inhibition as dTAFII230 and yTAFII145/130 in gel mobility shift, DNase I footprint, and in vitro transcription analyses (31, 33). Furthermore, TBPAS residues affecting hTAFII170 binding contact dTAFII230 (34). These results support the concept that occupancy of the TBP concave surface may be a general mechanism for TAFII regulation of TBP-DNA binding. Most TBP is associated with other proteins in the cell (44, 49). Given the present results, it seems that several TBP/TAF complexes have a built-in module that regulates TBP access to DNA to prevent spurious TATA-DNA interactions. Negative regulation of TBP-binding activity may therefore be a general conserved property of TBP/TAF complexes. This appears relevant given that TBP has a relatively high affinity for nonpromoter DNA (23). Additionally, the weak consensus for the TATA element results in numerous nonpromoter binding sites for TBP within the genome. Consistent with this view, TAFI48 of SL1 can prevent binding of TBP to the TATA box element of pol I promoters (12). Furthermore, the association of TBP with the SAGA subunits Spt3 and Spt8 regulates TBP-DNA binding (13). Reversibility of this concave inhibition would be a key feature to allow TBP to bind DNA. It has been proposed that transcriptional activators like c-Jun, VP16, GAL4, and EBNA2 may regulate dTAFII230/hTAFII250 inhibition of TBP binding to DNA (30, 32, 35, 41). Might hTAFII170 inhibition of TBP be similarly modulated? While hTAFII170 does not respond to activators tested so far (49), it may respond to other activators or components of the general transcription apparatus releasing its inhibition of TBP. Our present results provide a framework for these studies.
| |
ACKNOWLEDGMENTS |
|---|
We thank A. Berk for the pSRaMSVtkneoTBPAS convex mutants; H. Stunnenberg for pSG-ehTBP and pSG-ehTBPm3e; C. Kane for pET22-TFIIS, Y. Nakatani for pGST-dTAFII230 (2-81), pGST-dTAFII230 (82-156), and pGST-dTAFII230 (2-156); M. Rabenstein for pGST-dTRF-2; R. Romier for pACYC; L. Tora for pGST-ceTLF; and N. Zak for pGST-dTBP. We are grateful to N. Zak for communication of unpublished results. We acknowledge the contributions of F. Holstege in providing TFIIH. We thank F. Kavelaars for technical assistance and members of our laboratory for discussions and critical reading of this manuscript.
This work was supported by a grant to H.T.M.T. from Human Sciences Frontier Program Organization (HSFPO) and The Netherlands Organization for Scientific Research-Medical Sciences (NWO-MW).
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Physiological Chemistry, University Medical Center Utrecht, P.O. Box 85060, 3508 AB Utrecht, The Netherlands. Phone: 31-30-253-8981. Fax: 31-30-253-9035. E-mail: h.t.m.timmers{at}med.uu.nl.
Present address: Faculty of Medicine, Department of Molecular Cell
Biology, Leiden University, 2300 RA Leiden, The Netherlands.
Present address: Medical Genetics Centre, Erasmus University
Rotterdam, 3000 DR Rotterdam, The Netherlands.
§ Present address: Department of Gynecology, University Hospital Groningen, 9700 RB Groningen, The Netherlands.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Adamkewicz, J. I.,
K. E. Hansen,
W. A. Prud'homme,
J. L. Davis, and J. Thorner.
2001.
High-affinity interaction of yeast transcriptional regulator, Mot1, with TATA box-binding protein (TBP).
J. Biol. Chem.
276:11883-11894 |
| 2. |
Adamkewicz, J. I.,
C. G. F. Mueller,
K. E. Hansen,
W. A. Prud'homme, and J. Thorner.
2000.
Purification and enzymatic properties of Mot1 ATPase, a regulator of basal transcription in the yeast Saccharomyces cerevisiae.
J. Biol. Chem.
275:21158-21168 |
| 3. | Albright, S. R., and R. Tjian. 2000. TAF's revisited: more data reveal new twists and confirm old ideas. Gene 242:1-13[CrossRef][Medline]. |
| 4. | Andrade, M. A., C. Petosa, S. I. O'Donoghue, C. W. Muller, and P. Bork. 2001. Comparison of ARM and HEAT protein repeats. J. Mol. Biol. 309:1-18[CrossRef][Medline]. |
| 5. |
Auble, D. T., and S. Hahn.
1993.
An ATP-dependent inhibitor of TBP binding to DNA.
Genes Dev.
7:844-856 |
| 6. |
Auble, D. T.,
K. E. Hansen,
C. G. F. Mueller,
W. S. Lane,
J. Thorner, and S. Hahn.
1994.
Mot1, a global repressor of RNA polymerase II transcription, inhibits TBP binding to DNA by an ATP-dependent mechanism.
Genes Dev.
8:1920-1934 |
| 7. |
Auble, D. T., and S. M. Steggerda.
1999.
Testing for DNA tracking by Mot1, a SNF2/SWI2 protein family member.
Mol. Cell. Biol.
19:412-423 |
| 8. | Auble, D. T., D. Wang, K. W. Post, and S. Hahn. 1997. Molecular analysis of the SNF2/SWI2 protein family member Mot1, an ATP-driven enzyme that dissociates TATA-binding protein from DNA. Mol. Cell. Biol 17:4842-4851[Abstract]. |
| 9. | Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl. 1992. Short protocols in molecular biology. John Wiley & Sons, New York, N.Y. |
| 10. | Bagby, S., T. K. Mal, D. Liu, E. Raddatz, Y. Nakatani, and M. Ikura. 2000. TFIIA-TAF regulatory interplay: NMR evidence for overlapping binding sites on TBP. FEBS Lett. 468:149-154[CrossRef][Medline]. |
| 11. | Bai, Y., G. M. Perez, J. M. Beecham, and P. A. Weil. 1997. Structure-function analysis of TAF130: identification and characterization of a high-affinity TATA-binding protein interaction domain in the N terminus of yeast TAFII130. Mol. Cell. Biol. 17:3081-3093[Abstract]. |
| 12. |
Beckmann, H.,
J.-L. Chen,
T. O'Brien, and R. Tjian.
1995.
Coactivator and promoter-selective properties of RNA polymerase I TAFs.
Science
270:1506-1509 |
| 13. |
Belotserkovskaya, R.,
D. E. Sterner,
M. Deng,
M. H. Sayre,
P. M. Lieberman, and S. L. Berger.
2000.
Inhibition of TATA-binding protein function by SAGA subunits Spt3 and Spt8 at Gcn4-activated promoters.
Mol. Cell. Biol.
20:634-647 |
| 14. |
Bryant, G. O.,
L. S. Martel,
S. K. Burley, and A. J. Berk.
1996.
Radical mutations reveal TATA-box binding protein surfaces required for activated transcription in vivo.
Genes Dev.
10:2491-2504 |
| 15. | Cang, Y., D. T. Auble, and G. Prelich. 1999. A new regulatory domain on the TATA-binding protein. EMBO J. 18:6662-6671[CrossRef][Medline]. |
| 16. |
Chicca, J. J., II,
D. T. Auble, and B. F. Pugh.
1998.
Cloning and biochemical characterization of TAF-172, a human homolog of yeast Mot1.
Mol. Cell. Biol.
18:1701-1710 |
| 17. | Collart, M. A. 1996. The NOT, SPT3, and MOT1 genes functionally interact to regulate transcription at core promoters. Mol. Cell. Biol. 16:6668-6676[Abstract]. |
| 18. | Dantonel, J.-C., J.-M. Wurtz, O. Poch, D. Moras, and L. Tora. 1999. The TBP-like factor: an alternative transcription factor in metazoa? Trends Biochem. Sci 285:335-339. |
| 19. | Darst, R. P., D. Wang, and D. T. Auble. 2001. MOT1-catalyzed TBP-DNA disruption: uncoupling DNA conformational change and role of upstream DNA. EMBO J. 20:2028-2040[CrossRef][Medline]. |
| 20. |
Davis, J. L.,
R. Kunisawa, and J. Thorner.
1992.
A presumptive helicase (MOT1 gene product) affects gene expression and is required for viability in the yeast Saccharomyces cerevisiae.
Mol. Cell. Biol.
12:1879-1892 |
| 21. |
Goldman-Levi, R.,
C. Miller,
J. Bogoch, and N. B. Zak.
1996.
Expanding the mot1 subfamily: 89B helicase encodes a new Drosophila melanogaster SNF2-related protein which binds to multiple site on polytene chromosomes.
Nucleic Acids Res.
24:3121-3128 |
| 22. | Groves, M. R., N. Hanlon, P. Turowski, B. A. Hemmings, and D. Barford. 1999. The structure of the protein phosphatase 2A PR65/A subunit reveals the conformation of its 15 tandemly repeated HEAT motifs. Cell 96:99-110[CrossRef][Medline]. |
| 23. |
Hahn, S.,
S. Buratowski,
P. A. Sharp, and L. Guarente.
1989.
Yeast TATA-binding protein TFIID binds to TATA elements with both consensus and nonconsensus DNA sequences.
Proc. Natl. Acad. Sci. USA
86:5718-5722 |
| 24. |
Hampsey, M.
1998.
Molecular genetics of the RNA polymerase II general transcriptional machinery.
Microbiol. Mol. Biol. Rev.
62:465-503 |
| 25. |
Hernandez, N.
1993.
TBP, a universal eukaryotic transcription factor?
Genes Dev.
7:1291-1308 |
| 26. | Holstege, F. C. P., P. C. van der Vliet, and H. T. M. Timmers. 1996. Opening of an RNA polymerase II promoter occurs in two distinct steps and requires the basal transcription factors IIE and IIH. EMBO J. 15:1666-1677[Medline]. |
| 27. | Kang, J. J., D. T. Auble, J. A. Ranish, and S. Hahn. 1995. Analysis of the yeast factor TFIIA: distinct functional regions and a polymerase II-specific role in basal and activated transcription. Mol. Cell. Biol. 15:1234-1243[Abstract]. |
| 28. | Kim, J. L., D. B. Nikolov, and S. K. Burley. 1993. Co-crystal structure of TBP recognizing the minor groove of a TATA element. Nature 365:520-527[CrossRef][Medline]. |
| 29. | Kim, Y., J. H. Geiger, S. Hahn, and P. B. Sigler. 1993. Crystal structure of a yeast TBP/TATA-box complex. Nature 365:512-520[CrossRef][Medline]. |
| 30. |
Kobayashi, A.,
T. Miyake,
Y. Ohyama,
M. Kawaichi, and T. Kokubo.
2000.
Mutations in the TATA-binding protein, affecting transcriptional activation, show synthetic lethality with the TAF145 gene lacking the TAF N-terminal domain in Saccharomyces cerevisiae.
J. Biol. Chem.
276:395-405 |
| 31. |
Kokubo, T.,
S. Yamashita,
M. Horikoshi,
R. G. Roeder, and Y. Nakatani.
1994.
Interaction between the N-terminal domain of the 230-kDa subunit and the TATA box-binding subunit of TFIID negatively regulates TATA-box binding.
Proc. Natl. Acad. Sci. USA
91:3520-3524 |
| 32. |
Kotani, T.,
K.-I. Banno,
M. Ikura,
A. G. Hinnebusch,
Y. Nakatani,
M. Kawaichi, and T. Kokubo.
2000.
A role of transcriptional activators as antirepressors for the autoinhibitory activity of TATA box binding transcription factor IID.
Proc. Natl. Acad. Sci. USA
97:7178-7183 |
| 33. |
Kotani, T.,
T. Miyake,
Y. Tsukihashi,
A. G. Hinnebusch,
Y. Nakatani,
M. Kawaichi, and T. Kokubo.
1998.
Identification of highly conserved amino-terminal segments of dTAFII230 and yTAFII145 that are functionally interchangeable for inhibiting TBP-DNA interactions in vitro and in promoting yeast cell growth in vivo.
J. Biol. Chem.
273:32254-32264 |
| 34. | Liu, D., R. Ishima, K. I. Tong, S. Bagby, T. Kokubo, D. R. Muhandiram, L. E. Kay, Y. Nakatani, and M. Ikura. 1998. Solution structure of a TBP-TAFII230 complex: protein mimicry of the minor groove surface of the TATA box unwound by TBP. Cell 94:573-583[CrossRef][Medline]. |
| 35. |
Lively, T. N.,
H. A. Ferguson,
S. K. Galasinski,
A. G. Seto, and J. A. Goodrich.
2001.
c-Jun binds the N terminus of human TAFII250 to derepress RNA polymerase II transcription in vitro.
J. Biol. Chem.
276:25582-25588 |
| 36. | Madison, J. M., and F. Winston. 1997. Evidence that Spt3 functionally interacts with Mot1, TFIIA, and TATA-binding protein to confer promoter-specific transcriptional control in Saccharomyces cerevisiae. Mol. Cell. Biol. 17:287-295[Abstract]. |
| 37. |
Meyers, R. E., and P. A. Sharp.
1993.
TATA-binding protein and associated factors in polymerase II and polymerase III transcription.
Mol. Cell. Biol.
13:7953-7960 |
| 38. | Miller, J. 1972. Experiments in molecular genetics. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y. |
| 39. |
Muldrow, T. A.,
A. M. Campbell,
P. A. Weil, and D. T. Auble.
1999.
MOT1 can activate basal transcription in vitro by regulating the distribution of TATA binding protein between promoter and nonpromoter sites.
Mol. Cell. Biol.
19:2835-2845 |
| 40. |
Neuwald, A. F., and T. Hirano.
2000.
HEAT repeats associated with condensins, cohesins, and other complexes involved in chromosome-related functions.
Genome Res.
10:1445-1452 |
| 41. |
Nishikawa, J.-I.,
T. Kokubo,
M. Horikoshi,
R. G. Roeder, and Y. Nakatani.
1997.
Drosophila TAFII230 and the transcriptional activator VP16 bind competitively to the TATA box-binding domain of the TATA box-binding protein.
Proc. Natl. Acad. Sci. USA
94:85-90 |
| 42. | Pazin, M. J., and J. T. Kadonaga. 1997. SWI2/SNF2 and related proteins: ATP-driven motors that disrupt protein-DNA interactions? Cell 88:737-740[CrossRef][Medline]. |
| 43. |
Poon, D.,
A. M. Campbell,
Y. Bai, and P. A. Weil.
1994.
Yeast TAF170 is encoded by MOT1 and exists in a TATA box-binding (TBP)-TBP associated factor complex distinct from transcription factor IID.
J. Biol. Chem.
269:23135-23140 |
| 44. |
Poon, D., and P. A. Weil.
1993.
Immunopurification of yeast TATA-binding protein and associated factors.
J. Biol. Chem.
268:15325-15328 |
| 45. | Strubin, M., and K. Struhl. 1992. Yeast and human TFIID with altered DNA-binding specificity for TATA elements. Cell 68:721-730[CrossRef][Medline]. |
| 46. | Taggart, A. K. P., T. S. Fisher, and B. F. Pugh. 1992. The TATA-binding protein and associated factors are components of pol III transcription factor TFIIIB. Cell 71:1015-1028[CrossRef][Medline]. |
| 47. | Takada, S., J. T. Lis, S. Zhou, and R. Tjian. 2000. A TRF:BRF complex directs Drosophila RNA polymerase III transcription. Cell 101:459-469[CrossRef][Medline]. |
| 48. |
Thompson, J. D.,
D. G. Higgins, and T. J. Gibson.
1994.
CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice.
Nucleic Acids Res.
22:4673-4680 |
| 49. |
Timmers, H. T. M., and P. A. Sharp.
1991.
The mammalian TFIID protein is present in two functionally distinct complexes.
Genes Dev.
5:1946-1956 |
| 50. |
van der Knaap, J. A.,
J. W. Borst,
R. Gentz,
P. C. van der Vliet, and H. T. M. Timmers.
1997.
Cloning of the cDNA for the TAFII170 subunit of transcription factor B-TFIID reveals homology to global transcription regulators in yeast and Drosophila.
Proc. Natl. Acad. Sci. USA
94:11827-11832 |
| 51. |
Yokomori, K.,
C. P. Verrijzer, and R. Tjian.
1998.
An interplay between TATA box-binding protein and transcription factors IIE and IIA modulates DNA binding and transcription.
Proc. Natl. Acad. Sci. USA
95:6722-6727 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»